FDA Inspection 818784 — Sharp Healthcare

Sharp Healthcare — FEI 2083061

The FDA completed an inspection of Sharp Healthcare on February 13, 2013 in San Diego, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 13, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Diego, CA (United States)

Additional Details

IRB